Farudodstat (ASLAN003) is under investigation in clinical trial NCT03451084 (A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.